Switch theme
Sign up to access all valuation multiples
Cosmax Inc is a Korean-based specialized cosmetics research and development and manufacturing company. COSMAX develops and provides cosmetics to more than 600 cosmetics brands around the world. The key product consists of skincare, makeup, mask sheets, oriental medicine, haircare, functional cosmetics, and scents. Its products are also sold in Europe, North America, and Central and South America. The company also has four corporations in Shanghai and Guangzhou, China, Indonesia, and the United States.
1992
280
LTM Revenue $1.7B
LTM EBITDA $196M
$2.1B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
COSMAX has a last 12-month revenue (LTM) of $1.7B and a last 12-month EBITDA of $196M.
In the most recent fiscal year, COSMAX achieved revenue of $1.6B and an EBITDA of $183M.
COSMAX expects next 12-month revenue of XXX and NTM EBITDA of XXX
See COSMAX valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.7B | XXX | $1.6B | XXX | XXX | XXX |
| Gross Profit | $329M | XXX | $304M | XXX | XXX | XXX |
| Gross Margin | 20% | XXX | 19% | XXX | XXX | XXX |
| EBITDA | $196M | XXX | $183M | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 12% | XXX | XXX | XXX |
| EBIT | $144M | XXX | $128M | XXX | XXX | XXX |
| EBIT Margin | 9% | XXX | 8% | XXX | XXX | XXX |
| Net Profit | $75.5M | XXX | $62.4M | XXX | XXX | XXX |
| Net Margin | 4% | XXX | 4% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $320M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, COSMAX's stock price is KRW 210000 (or $153).
COSMAX has current market cap of KRW 2.38T (or $1.7B), and EV of KRW 2.94T (or $2.1B).
See COSMAX trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.1B | $1.7B | XXX | XXX | XXX | XXX | $6.42 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, COSMAX has market cap of $1.7B and EV of $2.1B.
COSMAX's trades at 1.4x EV/Revenue multiple, and 11.7x EV/EBITDA.
Equity research analysts estimate COSMAX's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
COSMAX has a P/E ratio of 22.9x.
See valuation multiples for COSMAX and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.7B | XXX | $1.7B | XXX | XXX | XXX |
| EV (current) | $2.1B | XXX | $2.1B | XXX | XXX | XXX |
| EV/Revenue | 1.3x | XXX | 1.4x | XXX | XXX | XXX |
| EV/EBITDA | 10.9x | XXX | 11.7x | XXX | XXX | XXX |
| EV/EBIT | 14.9x | XXX | 16.8x | XXX | XXX | XXX |
| EV/Gross Profit | 6.5x | XXX | n/a | XXX | XXX | XXX |
| P/E | 22.9x | XXX | 27.8x | XXX | XXX | XXX |
| EV/FCF | -417.2x | XXX | -30.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialCOSMAX's last 12 month revenue growth is 15%
COSMAX's revenue per employee in the last FY averaged $5.6M, while opex per employee averaged $0.6M for the same period.
COSMAX's rule of 40 is 25% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
COSMAX's rule of X is 49% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for COSMAX and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 15% | XXX | 15% | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 12% | XXX | XXX | XXX |
| EBITDA Growth | 20% | XXX | 32% | XXX | XXX | XXX |
| Rule of 40 | 25% | XXX | 27% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 49% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $5.6M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.6M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 5% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 0% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 11% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
COSMAX acquired XXX companies to date.
Last acquisition by COSMAX was XXXXXXXX, XXXXX XXXXX XXXXXX . COSMAX acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was COSMAX founded? | COSMAX was founded in 1992. |
| Where is COSMAX headquartered? | COSMAX is headquartered in South Korea. |
| How many employees does COSMAX have? | As of today, COSMAX has 280 employees. |
| Who is the CEO of COSMAX? | COSMAX's CEO is Mr. Byung-man Lee. |
| Is COSMAX publicy listed? | Yes, COSMAX is a public company listed on KRX. |
| What is the stock symbol of COSMAX? | COSMAX trades under 192820 ticker. |
| When did COSMAX go public? | COSMAX went public in 2014. |
| Who are competitors of COSMAX? | Similar companies to COSMAX include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
| What is the current market cap of COSMAX? | COSMAX's current market cap is $1.7B |
| What is the current revenue of COSMAX? | COSMAX's last 12 months revenue is $1.7B. |
| What is the current revenue growth of COSMAX? | COSMAX revenue growth (NTM/LTM) is 15%. |
| What is the current EV/Revenue multiple of COSMAX? | Current revenue multiple of COSMAX is 1.3x. |
| Is COSMAX profitable? | Yes, COSMAX is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of COSMAX? | COSMAX's last 12 months EBITDA is $196M. |
| What is COSMAX's EBITDA margin? | COSMAX's last 12 months EBITDA margin is 12%. |
| What is the current EV/EBITDA multiple of COSMAX? | Current EBITDA multiple of COSMAX is 10.9x. |
| What is the current FCF of COSMAX? | COSMAX's last 12 months FCF is -$5.1M. |
| What is COSMAX's FCF margin? | COSMAX's last 12 months FCF margin is 0%. |
| What is the current EV/FCF multiple of COSMAX? | Current FCF multiple of COSMAX is -417.2x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
